Abstract:Electrochemical aptamer-based (EAB) sensors are among the only generalizable sensing platforms that resist fouling enough to function directly in bodily fluids and in situ in the living body. Already, these sensors have enabled the real-time measurement of a range of small molecule targets in vivo, including pharmaceuticals and drugs of abuse. EAB sensors consist of an electrode-attached, redox reporter-labeled aptamer that binds to its target species. Target binding causes a shift in electron-transfer rate between the redox reporter and electrode surface, easily detected by a range of electrochemical techniques. Here, we explore the application of EAB sensors to minimally-invasive molecular monitoring. Specifically, we adapt the platform to a microneedle device format. Microneedles can provide direct access to the skin’s interstitial space – a bodily compartment that holds valuable information ranging from drug distribution and immune status. And because microneedles can penetrate into the top layers of the skin with minimal nerve endings, they can avoid eliciting notable pain responses. In this work, we demonstrate the substantial miniaturization of the sensing platform into electrodes thinner than a human hair, and then integrate them with ultra-fine, hollow microneedles. To ensure needle sterilizability and sharpness while avoiding complex fabrication, we utilize commercial off the shelf stainless steel microneedles. Using an EAB sensor responding to the high-toxicity small molecule drug, vancomycin, as a model system, we achieve quantitative measurements directly in body temperature, undiluted whole blood. Building on this milestone, we explore the application of the sensors when inserted into porcine skin. In porcine skin (a common proxy for human skin), we observe facile microneedle penetration and stable electrochemical signaling. Because of the individual addressability of the sensing electrodes and the generalizability of the aptamer platform, this technology is capable of multiplexed, simultaneous detection of many different molecular targets. Thus, microneedle-enabled aptamer-based sensors offer a promising route forward for non-invasive physiological monitoring – applicable to therapeutic drug monitoring, pain-free biomarker detection, and disease management.

Real-time monitoring of daunorubicin pharmacokinetics with nanoporous electrochemical aptamer-based sensors in vivo

Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring

Real-Time Evaluation of Live Cancer Cells by an in Situ Surface Plasmon Resonance and Electrochemical Study.

Real-time Detection of the Interaction Between Anticancer Drug Daunorubicin and Cancer Cells by Au-MCNT Nanocomposites Modified Electrodes

Design and Fabrication of New Anticancer Sensor for Monitoring of Daunorubicin Using 1-Methyl-3-octylimidazolinium Chloride and Tin Oxide/nitrogen-Doped Graphene Quantum Dot Nanocomposite Electrochemical Sensor.

A Highly Sensitive Resonance Scattering Based Sensor Using Unmodified Gold Nanoparticles for Daunomycin Detection in Aqueous Solution

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.

Real-Time in Vivo Quantitative Monitoring of Drug Release by Dual-Mode Magnetic Resonance and Upconverted Luminescence Imaging

Reduced Graphene Oxide and Gold Nanoparticles-Modified Electrochemical Aptasensor for Highly Sensitive Detection of Doxorubicin

Ratiometric Monitoring of Intracellular Drug Release by an Upconversion Drug Delivery Nanosystem.

Construction of an Electrochemical Aptamer-Based Sensors for Rapid Quantification of the Anticancer Drug Imatinib in Blood to Improve Drug Bioavailability at Microdoses

Electrochemical Sensor for the Evaluation of Doxorubicin from Novel Pharmaceutical Formulations and Serum

Microneedle Enabled Electrochemical Aptamer-Based Sensing: Real Time Measurements Using Stainless Steel Microneedles

Guanine-Based DNA Biosensor Amplified with Pt/SWCNTs Nanocomposite as Analytical Tool for Nanomolar Determination of Daunorubicin as an Anticancer Drug: A Docking/Experimental Investigation

Ratiometric Real-Time Monitoring of Hydroxyapatite–doxorubicin Nanotheranostic Agents for On-Demand Tumor Targeted Chemotherapy

A Nanosensor for Precise Discrimination of Nephrotoxic Drug Mechanisms Via Dynamic Fluorescence Fingerprint Strategy

Aptamer-based Upconversion Fluorescence Sensor for Doxorubicin Detection

Implantable Hydrogel-Protective DNA Aptamer-Based Sensor Supports Accurate, Continuous Electrochemical Analysis of Drugs at Multiple Sites in Living Rats

A microsensing system for the in vivo real-time monitoring of local drug kinetics

SERS Endoscopy for Monitoring Intracellular Drug Dynamics

Integrated Electrochemical Aptasensor Array toward Monitoring Anticancer Drugs in Sweat